Immuneering Corp (IMRX) — Financial Flexibility Index
Immuneering Corp (IMRX) has a Financial Flexibility Index of -0.92x as of September 2025. Free cash flow of $-11.97 Million (operating CF $-11.98 Million minus capex $7.25K) represents -1% of total liabilities ($13.08 Million). Also explore Immuneering Corp (IMRX) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Immuneering Corp Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Immuneering Corp across 6 annual periods. Check asset allocation strategy of Immuneering Corp to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Immuneering Corp (2019–2024)
Year-by-year free cash flow to debt coverage for Immuneering Corp. For the full company profile including market capitalisation, see market value of Immuneering Corp.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.85x | $-54.91 Million | $-55.00 Million | $11.33 Million | ▼ -19.7% |
| 2023 | -4.05x | $-48.63 Million | $-48.97 Million | $12.01 Million | ▼ -16.9% |
| 2022 | -3.46x | $-43.36 Million | $-44.10 Million | $12.52 Million | ▼ -20.7% |
| 2021 | -2.87x | $-30.79 Million | $-30.85 Million | $10.72 Million | ▼ -1100.3% |
| 2020 | -0.24x | $-14.57 Million | $-14.62 Million | $60.90 Million | ▼ -11.6% |
| 2019 | -0.21x | $-4.42 Million | $-4.44 Million | $20.63 Million | — |